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PREFACE 
 
The application of informed consent in research in developing countries 
continues to be a topical and complex issue. The debate concerning informed 
consent has become even more relevant in light of the groundswell of 
international collaborative research that is conducted in developing countries. 
The discussion centres on the uncertainties of the application of informed 
consent in developing countries based on the normative criteria set out in 
international codes and regulations. Although the ethical and legal basis of 
obtaining valid informed consent is incontestable, contextual differences 
between developed and developing countries is a key problem. For example, it 
is debated if the tenets of ‘Western’ research ethics, mainly in the application of 
a written informed consent model can truly be applied in the African context. 
 
The question is whether the participants of research when conducted in 
developing countries actually are “informed” in the consent process.  There are 
perceptions that the protective instruments that guide researchers on how to 
obtain informed consent from research participants are not robust and sensitive 
enough for developing countries needs. In literature, some have questioned the 
relevance of its purist application in the context of developing countries as 
‘overly paternalistic’. Others have argued from the view point that the 
Eurocentric approach recommended in obtaining informed consent in 
developing countries has the potential to undermine cultural norms and 
traditions. In the latter argument, concerns are raised about the principle of 
respect for persons / ‘autonomy’ and its applicability in so-called communitarian 
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societies. To overcome some unique hurdles, there are voices that call for tailor-
made processes for obtaining informed consent to suit the prevailing context, 
suggesting therefore that there should be some variance in its application. The 
importance of the issue of informed consent becomes critical as much 
international collaborative research takes place in Africa where health services 
are often inadequate and research is perceived by participants as a means of 
ameliorating some of their suffering.  
 
Given the philosophical and the ‘universal’ ethical foundations at the heart of the 
international regulations and codes on the issue of informed consent, there is a 
need to further  explore the foundation of these perceptions as they raise 
various ethical issues which need to be discussed.  
 
The question concerned in this research report is “is there unfinished business 
not addressed in the process of obtaining informed consent in developing 
countries?” 
In order to answer this question, it is necessary to look at some of the requisites 
for the application of informed consent principles. I will examine whether the 
content of the commonly cited ethical codes and regulations (originally initiated 
in developed countries) are sufficiently broad enough to explain the aims of 
obtaining informed consent, the steps to be taken in obtaining informed consent 
and the structures necessary for its facilitation. In addition I will examine 
whether the intent of the codes and regulations take cognizance of socio-
cultural variations. In other words, is the environment sufficiently conducive to 
apply the concept and are the guidelines flexible enough to deal with “unusual 
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circumstances”.  In consideration of the latter, I consider the question of the 
adequacy of structures to ensure the essence of respect for persons is not lost 
in dealing with “unusual circumstances”. I contend that if the answer is in the 
affirmative it is only then can it be said that the principles of informed consent 
are being adequately addressed and meet the moral, ethical, and legal 
obligations of research activities.  
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CHAPTER DIVISIONS 
Chapter One gives an overview of informed consent as a concept and outlines 
its importance in research. The literature review in this chapter is meant to 
describe the diverse views pertaining to informed consent. The end of the 
chapter describes the aims and objectives of this paper and briefly justifies why 
the topic merits further discussion. 
 
Chapter Two explains the Ethical and Legal Frameworks for analysis of the 
concept of informed consent and explores the extent the various declarations, 
codes, guidelines and some regulations pertinent to the obtaining of informed 
consent in research  
 
Chapter Three focuses on South Africa and will give a description of Legal and 
Ethical documents supporting informed consent for good Research Activities.  
 
Chapter Four provides some ethical, legal and cultural commentary on Informed 
Consent in Research. 
  
Chapter Five highlights the “unfinished business” in informed consent and 
Recommendations for its further development. 
 
The conclusion will suggest how we might try to overcome some of the 
obstacles and enhance the obtaining of informed consent in an ethical manner 
in research but at the same time avoid dogmatism in its application.  
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CHAPTER 1: The Importance of Informed Consent In Research  
This chapter will analyse the concept of informed consent and its importance in 
research. The literature review highlights the contentious areas of informed 
consent in research. The end of the chapter will describe the aims and 
objectives of this paper and briefly justify why the topic merits further discussion. 
INTRODUCTION  
Research is important and is vital for the advancement of medicine. The ethical 
basis of medical research is to discover interventions which have the actual or 
potential ability to save lives, and improve peoples’ well being.  These 
interventions can be at prophylactic, diagnostic, or therapeutic levels. Research 
may be conducted on patient volunteers or healthy participants. Patients can be 
based within or outside hospital settings. Crucial to the endeavour of health 
research is the realisation that although volunteers could get benefits in various 
ways, in general, the majority may not qualitatively and quantitatively benefit 
from research results. Although, sound scientific research methods and working 
to maintain the best interest of the research participants’ welfare are crucial, 
they are not sufficient to render the research ethical if respect for persons / 
autonomy and informed consent are ignored. The two critical reasons why 
informed consent (IC) should be obtained from research participants prior to 
and during the research process is to ensure that participants’ rights and 
welfare are protected as well as and to ensure that they can make autonomous 
decisions about whether or not to participate in  research. 
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Informed consent (IC) has been a misnomer in the research community for a 
long time. It appears that in many instances participation was acquired through 
overt paternalism, deception and coercion by researchers. The extent of 
transgressions in research in relatively modern times is best demonstrated by 
Nazi doctors during the Holocaust (Beauchamp & Childress, 1989:142-143).  
The Nuremberg Code (1947) was the first document, which was participant – 
centred. It did so by clearly articulating the supremacy of research participants 
and the importance of obtaining consent from them.  At the same time it clearly 
spelled out the elements needed to fulfil the conditions of obtaining consent. In 
unequivocal terms it also addressed the moral and legal responsibilities that 
researchers have towards to research participants. The Nuremberg Code to an 
extent, therefore, cemented the bridge between the ethical basis of doing 
research and the legal requirements. The legal tone of the Code reflects the 
role played by judges in crafting it.  
 
Following the War Crimes Tribunals after World War II, the idea of obtaining 
“consent” from subjects / participants in medical research was first conceived. 
Later, when research activities became more common, consent was 
reconceptualised as “informed consent”. The goal was to seek solutions for the 
protection of individuals from unethical researchers through application of the 
ethical mechanisms involved in ensuring ‘consent’ was truly ‘informed’.  
It is not surprising therefore that the protection of individual rights and welfare 
are the principal reason why the concept of informed consent in health research 
in developed countries received considerable attention. Because their 
governmental systems reflected the idea of individual autonomy and rights, 
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particularly in the context of the USA, the literature from at least the 1960’s 
shows much discussion concerning the meaning, scope, role and application of 
informed consent (ibid).   
 
The four basic principles of biomedical ethics, respect for persons / autonomy, 
non-maleficence, beneficence and justice extend to research ethics. In the 
history of research ethics, philosophers, lawyers, social scientists and belatedly 
the research fraternity argued for the promulgation of the principle of autonomy 
and respect for persons as a cornerstone of informed consent as opposed to 
exclusively relying on the principle of beneficence (Wear, 1993:111-112).The 
principle of beneficence was first used as the means by which some assurance 
was given that the safety of participants in research was monitored (ibid). The 
principle of beneficence (to do good - actively promote the good of others) if 
inappropriately applied can result in paternalism and even worse coercion. 
Because history has revealed that great breaches of research ethics in the 
guise of beneficence occurred in developed countries (e.g. Tuskegee Syphilis 
study, Willowbrook) some may argue this gave impetus for further investigation 
of the issue of IC. This did occur in developed countries and later spread 
globally where other voices were raised concerning the applicability of IC in 
different cultural contexts.   
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An Overview of Issues Pertaining to Informed Consent in Developed and 
Developing Countries 
 
The application of the principles grounding informed consent in both developed 
and developing countries is not straight forward, in fact, it is complex.  In part, 
this is due to the interpretation of informed consent from the legal and ethical 
perspectives whose intent and justification differs resulting in a complication of 
the ‘universality’ of its application. The legal perspective is principally driven by 
rules for the purpose of seeking legal redress. Whereas the ethical perspective 
looks at the ways in which a mutually beneficial moral relationship between the 
researcher and the-would-be-participant can be realized. In addition, there is a 
difference between legal and ethical justifications. The former is to prove 
negligence and the latter to encourage collaboration decision making (Fadel & 
Beauchamp, 1986). Beyond these considerations Parker asserts that IC plays a 
preventive role as it gives a warning of potential areas of ethical concern and 
helps with strategies aimed at mitigating their occurrences (Parker, 1995:520-
523). 
 
It is important to note that the IC process does not occur in isolation but is 
influenced by the context in which it applied. The context is composed of any 
factors such as the preponderance of vulnerable groups, educational levels, 
un/employment levels and types, poverty, and poor if any healthcare structures.  
Moreover, research is often conducted in countries where gender inequality is a 
norm, and where communal consent (at least supposedly) trumps individual 
consent. The context is further compounded by institutional constraints such as, 
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poor or inadequate health care management as well as insufficient resources 
(financial and human). Moreover, the legacy of colonialism is still pervasive, and 
many still accept authority without questions (Dhai, 2005:595-597). Conditions 
such as these could have a direct impact on obtaining informed consent from 
participants. 
 
Although individual informed consent is a universal requirement in research, 
studies have shown that this  is not as universally applied as required in both 
the developed and developing countries. Infringements have occurred  at 
various levels of obtaining  IC ranging from: involuntary participation in  
research, sketchy  understanding of intent of the research by the participants,  
poor imparting of  risks and to an extent exaggeration of  benefits that may 
occur, and finally, insufficient  information imparted  to the participants to make 
decisions thus negating  rational  informed choices.  
 
Literature review – background 
 
‘Consent’ in the Oxford dictionary means inter alia “approval” agreement, “seal 
of approval”. This definition does not clarify whether there is a condition 
attached to approval e.g. if disclosure of all information is necessary. But 
informed consent is normative in that “any consent is informed if it satisfies the 
operative rules governing the practice” (Fadel & Beauchamp, 1986:30-33) 
Informed consent assumes that the consent is given provided that adequate 
and relevant information is given to the participant prior to the intervention. The 
information should include risks that might occur. Informed consent requires that 
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a person is competent or has the capacity to give consent. Concerning capacity, 
Dworkina (1988:104-108) says … capacity refers to the ability to reflect one’s 
motivational structure. 
 
So the idea of capacity, so defined, calls for the potential participant to have the 
ability to think about why he or she is or is not interested in research 
participation. The reliance on the researcher to disclosure relevant information 
which will feed into the potential participant’s final decision then becomes a vital 
ethical directive. Moreover, a demonstrable understanding of the information by 
the participant is necessary to the assurance of IC.  According to Emanuel 
(2005),  
 
… understanding is not what the researcher thinks is important, 
but what is important, is for participants to decide whether a 
study fits with their values and beliefs and to decide whether the 
risks are worthwhile …  
 
He (ibid) also identified studies that show that the more educated a participant 
is, the more they are likely to have higher scores concerning understanding 
information. Although this is not surprising, it has bearing on the fact that poor 
people in developing countries may lack basic education and therefore may 
score low in understanding what has been said to them – even if presented in 
their home languages.  This concern was echoed in a study from Ghana that 
revealed that participants were deficient in understanding some aspects of the 
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research and this was revealed as attributable to lack of education (Hill et al , 
2008: 48-53). 
 
Four broad themes which may be used to assess a participant’s competence 
are outlined in an article by Levine (2003:197-201). He suggests:  
 
• That the participant has the ability to make a reasonable choice when 
given alternatives to choose from which to choose.  
 
• That the participant understands the basic tenets of the information about 
the research.  
 
• That the participant has the capacity to make a rational choice and;  
 
• That the participant understands the overall implications of being 
involved a research project. 
 
As shown above, the four themes all relate to respecting a participant’s rational 
choice, or their autonomy. Linked to the IC consent process is respect for 
autonomy. It is important to note that respect for autonomy is not just the 
capacity to reflect on ones action but also the capacity to critically reflect about 
the course of action to take, and the capacity to change one’s mind “in the light 
of higher order preferences” as Dworkin (1989b; 108) puts it. By being given a 
choice of actions, and assuring that a potential participant understands the aims 
of the research, e.g. what is and is not required in participation, the burdens and 
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the benefits in the context of researcher fidelity and then allowing a decision 
without prejudice equals validation of one’s autonomy (Levine, 1991:207-236).   
 
The participation or not in research studies should be left to the participant’s 
discretion. By implication this means that the participant’s choice is voluntary. 
This is in accordance with respect for their autonomy.  The qualifier for 
voluntariness is that voluntary consent should be void of duress or undue 
inducement (Darr, 1991:169-170).  
 
The reality is that “voluntariness can be compromised” (Kass et al, 2005;1-5). 
Some of the factors which may compromise ‘voluntariness’ are poverty , limited 
access to medical care , and patterns of decision making related to gender , 
socio economic conditions,  or culture (Benatar, 2002:1131-1141)  One of the 
difficulties in measuring consent and choice is dependent on the type of 
theoretical underpinnings used to measure them (Jepson, at al, 2005:192-196).   
 
Information, its boundaries and expression, is a difficult problem in the research 
context. One major hurdle is that the way information is imparted is not value 
free (Edwards & Elwyn, 2001:9-13). In other words, the values of researchers 
(e.g. if completion of their study is over-prioritized over actual participant 
burdens) may influence the type of information provided to the potential 
participant. Thus the principle of autonomy may be distorted and the type of 
choices made by potential participants may be skewed unless equipoise is 
maintained.  
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While autonomy is the fundamental principle in informed consent, it is closely 
related to other principles. It is in the participants best interest (the principle of 
beneficence-to do good; actively pursue the good) of participants to have 
adequate and pertinent information in order to make their own informed 
decisions. Respecting participants’ capacity to make their own autonomous, 
informed decisions, has a bearing on respecting human dignity (principle of 
non-maleficence-to do no harm; to not knowingly inflict harm).  
 
The principle of justice (fairness; equity) requires that one must be treated with 
in accordance with what is just and fair. It follows that when one participates in 
research it is consented to on the basis of informed choice and so in the spirit of 
justice, the participant is being treated justly and fairly. 
 
The difficulties of obtaining informed consent from research participants are well 
recognized in situations where there are educational, linguistic and cultural 
differences between the researchers and the participants. A study from Kenya 
highlighted the challenges confronted by researchers in obtaining truly informed 
consent as a result of the participants’ lack of understanding of the research 
aims (Molyneux, at al, 2004:2547-2559). This also was of concern in a Malaria 
study conducted in Uganda (Pace,et al 2005). In this particular research, 
parents did not fully understand that their children were at risk because of the 
children would be randomized in the study.  Although these represent real 
hurdles, social and cultural barriers should not be used as a reason to negate 
the IC process (Newton & Appiah-Poku, 2007:149-156). Rather, such examples 
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show that there is a greater need to investigate ways in which the IC process 
can be realized while being culturally and socially aware of inherent difficulties.   
 
Particularly in developing countries, one of the roles of informed consent is to 
prevent the notion of the therapeutic misconception on the part of participants.  
“Therapeutic misconception is a major barrier to genuine informed consent” 
(Lidz & Applebaum, 2002:55-63).  Participants who take part in clinical research 
sometimes mistake clinical research for treatment. It is a fact of research in 
countries where healthcare resources are scarce that sometimes self interest 
motivates people to participate in research with the hope of getting some benefit 
even if the research will not benefit them at all (Gotay, 1991:569-577). 
Desperate for some type of care, the danger of therapeutic misconception is 
common and amplified. This naturally impinges on the informed consent 
process as the patient’s perception, or hope of assistance serves as a 
psychological barrier to a true understanding of IC. This barrier to real 
comprehension may be taken advantage of by unethical researchers and is a 
vital issue to consider in research ethics (Schaeffer, Krantz, & Wichman, 
1996:261-268).  
 
Justification for this Inquiry 
 
There is a need to constantly review the concept of informed consent and the 
process of obtaining a valid informed consent in the light of the rapid 
proliferation of collaborative research in developing regions, especially Africa.   
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The aim of this paper is to explore whether there is a disconnect  between 
existing guidelines, ethics structures and currently held views and perceptions 
of obtaining informed consent in developing countries resulting in the 
fundamental  principles underlying it being ignored.  
 
Objectives  
 
• To examine the concept of informed consent and its relation to 
autonomy. 
• To review the streams of thinking that dominate informed consent in 
literature as it pertains to research. 
• To examine the present International and National guidelines on 
informed consent. 
• To propose that informed consent is a vital research process which 
needs to be continuingly re-evaluated; that there will always be 
‘unfinished business’ e.g. in the light of new information, cultural changes 
and research developments.  
• To suggest ways in which the research process may be fortified to 
ensure the protection of human participants in research.   
 
Research Methodology 
 
Sources included books, articles and documents pertaining to issues on 
informed consent in developing countries which were read then reflected upon.  
The variables for analyses were 1) International and national research ethics 
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declarations, codes and regulations. 2) Ethical / philosophical theories that 
speak to informed consent. 3)  Other general articles pertaining to informed 
consent. Print media were the source of information including academic search 
engines in the gathering of research data. Arguments in support or refuting the 
claims that the informed consent process is not applicable in developing 
countries were considered.  
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CHAPTER 2: Ethical and Legal Frameworks for the Analysis of 
Informed Consent  
 
In this chapter, I will explain the Ethical and Legal Frameworks for analysis of 
the concept of informed consent and explore the extent the various 
declarations, codes, guidelines and some regulations pertinent to the obtaining 
of informed consent in research  
 
Ethical Framework  
From a deontological perspective, a researcher has a duty to conduct research 
for the good of individuals. However, within that duty the line has to be drawn 
between treating participants as autonomous agents and the stringent 
requirements of science and research.  In a Kantian view, one of the duties we 
have is to treat all people as ends in themselves, and never as a means to an 
end.  It is morally justified and a moral duty to sanction ethical research for the 
benefit of peoples’ well-being but not at the expense of individual informed 
consent as the “means does not justify the end”.  
 
The Utilitarian theory looks at research in a different perspective.  This is 
because it is a view based on Consequentialism. In this perspective, a right 
action is one that brings about the best consequences for all concerned. 
Although doing research is morally justifiable on the assumption of maximising 
utility (happiness / good / pleasure) or benefits for the majority of a population, 
the individual participants’ value might be considered less than the attainment of 
good research outcomes which would benefit the aggregate. However, there 
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are many different ways of interpreting utilitarianism and because it is a moral 
theory, researchers are bound to act within its ethical framework.   
 
The foundational platform for ethical research is strongly influenced by principle- 
based ethics (principlism) which was developed by Beauchamp and Childress. 
They based their work on a synthesis of deontology, Utilitarianism and the 
works of W. D. Ross. From these moral theories, they developed key principles 
which they consider ground the basis of medical practice. The principles are 
autonomy, beneficence, non-maleficence and justice. Although each of the 
principles are prima facie and can be overridden by the another depending on 
the most compelling situation at hand, this way of reasoning became the most 
common ethical system used by healthcare professionals. In the healthcare 
setting, respect for persons / autonomy, maximizing benefits and minimizing 
harm (beneficence and non-maleficence), and fairness (justice) are core 
concepts of being a professional and in the concept of professionalism.  
 
Application of Principlism in Research  
 
There are four basic principles of biomedical ethics which serve to ground the 
ethical duties of researchers. These principles are Autonomy / Respect for 
persons, Beneficence, Non-maleficence and Justice.  
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Autonomy 
 
As a concept, autonomy or autonomous, can be traced back to the ancient 
Greek governmental system which assigned ‘autonomy’ (auto – self and 
nomous – governing) to the states within its boundaries. Many philosophers 
contributed to the idea that humans also should be treated autonomously e.g. 
capable of and should be given the opportunity to make their own individual 
choices. One of the most influential was Immanuel Kant who clearly linked the 
idea of autonomy with that of respect for persons. The obligation to respect the 
inherent dignity and worth of every human is present in all liberal, moral and 
political activities which emphasise issues such as individual freedoms and the 
right to make choices.  Any theoretical analysis of informed consent is therefore 
underpinned by the autonomy momentum (Seedhouse, 2001: 184-185).  
 
The Kantian approach revolutionized the way research participants should be 
treated by laying the foundation for respect for persons. A person is 
autonomous when decision making and choice is entirely his/hers. This is the 
basis of human dignity. Autonomy is likened to two sides of a coin i.e. that of a 
person making hers/his own decisions without coercion whilst simultaneously 
making reasoned choices. It follows then that anything less than treating a 
person as an end in his/herself is tantamount to the denial of his/her autonomy.   
 
Respect for persons as autonomous beings presupposes that they are 
competent to make choices. Therefore the giving of IC is valid when autonomy 
is respected (Munson, 2004:780-781).   Where the participant is competent and 
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able to exercise free choice respecting autonomy is pretty straight forward. 
Problems arise where people are not in a position to do so e.g. inability to 
understand, low levels of literacy, poverty, mentally impaired or under the legal 
age of adulthood. In cases where the individual is not competent and thus does 
not have the capacity to make a valid informed decision, the “best interest1” 
principle must be drawn upon and the individual must be represented by a legal 
guardian. In such ways, the dignity and worth of each person can be realized.  
 
Beneficence 
Ethical research endeavours to ultimately benefit individuals, more importantly 
to benefit whole populations through knowledge gained or discoveries as a 
result of the research. The principle of beneficence in the context of research is 
an act of preventing, removing or improving a particular situation. The principle 
of beneficence is therefore core to research. This principle obligates 
researchers to maximise possible benefits (Gillon, 1997:167). It relates to the 
concept of informed consent in the following manner, firstly, it aims at directing 
researchers to do everything possible to respect the values and dignity of the 
research participants. This is done only if researchers put into practice and 
adhere to the elements of informed consent (Ganzini et al 2005: 100-104). 
Secondly, through assessing and foreseeing the potential risks and potential 
benefits of the research and informing the participants about them adherence to 
beneficence assures fairness. Thirdly, by ensuring that participants are informed 
about the research process in terms of any conveniences the research will have 
on their personal lives adherence to the principle of beneficence may prevent 
                                                
1
 The best interest principle is sometimes relied upon to guide decision-making in circumstances when the 
patient is incompetent  
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any misconception on the part of the participant. As mentioned previously, 
beneficence has been misused by healthcare professionals in the form of strong 
paternalism. In strong paternalism, the healthcare professional (e.g. doctor, 
researcher, nurse) does not permit the patient to make his or her own decision 
based on provision of e.g. available information, understanding and consent. 
Rather the healthcare professional makes all the decisions for the patient 
concerning his or her care.  In addition, there is usually an imbalance of 
knowledge, hence power between the patient / participant and doctor/ 
researcher. A doctor / researcher is generally perceived as more knowledgeable 
about the treatment / research than is the patient/ participant. 
 
Non-maleficence 
The principle of non-maleficence or not inflicting harm stems from the Latin 
maxim Primum non nocere meaning “first do no harm”. This principle is 
particularly apt in the context of research. Medical research history, as 
demonstrated in this paper, is littered with research that did harm to many 
people. The transgressions of informed consent processes can virtually do harm 
to the participants. The application of this principle in informed consent puts an 
obligation on researchers that potential participants must be told about the risks 
or harms of the research. These risks or harms can be physical discomfort or 
pain, psychological, economic or social in nature. Harm also can be at individual 
level or extended to groups.  Harm must be weighed against the benefits of the 
research. This is a major reason that potential participants must be informed in 
detail about research processes. For example, it is incumbent upon the 
researcher to inform the participants about how confidentiality will be observed 
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by the researcher and to whom the research results will be reported to and 
whether at any point the anonymity will be broken.    
Justice 
In research, the principle of justice can be applied at three protective levels. 
One level is that of obtaining informed consent. Research ethics committees 
therefore examine whether justice as protective mechanism is applied by 
researchers through ensuring that provision for obtaining informed consent is 
included by researchers (WHO, 2001). Can justice be said to have been applied 
when the participants agree to take part in research when they might not 
understand the enormity of the risks entailed in the research? In other words, 
can individual consent to research be sufficient? The principle of justice in 
research is grounded on protecting vulnerable groups from being forced to take 
unreasonable risks. By looking at the principle of justice through the lens of 
risks, research ethics committees on behalf of the participants make a decision 
of about the reasonableness of the risks. If they are perceived to outweigh the 
benefits the protocol is rejected.   Lastly, the justice principle is applied as a 
protective mechanism against exploitation (Macklin, 1998:131-145). In 
developing countries like South Africa this is particularly important where 
poverty is rife that people are not over researched when there are no benefits. It 
is particularly so, when perverse incentives2 are offered.  
 
 
The principle of justice is linked to the concepts fairness and equity.  Justice, 
particularly its sub-set distributive justice is particularly applicable to research in 
                                                
2
 A perverse incentive is an offer of a desirable good in excess characterised by inappropriateness. It 
compromises judgement, may lead to risk taking eroding autonomy and therefore informed consent. This 
is especially true in vulnerable groups.  
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developing countries. In the context of research distributive justice requires that 
participants have equitable access to research or basic healthcare.  This means 
no one must be prejudiced or excluded from being a research participant for 
non-scientific reasons (especially during clinical trials). Distributive justice also 
concerns access to information, and the just distribution of goods and services.  
 
Legal Frameworks  
“Valid” as opposed to “informed” consent is the terminology usually used in law 
(Andanda, 2006:41-43). I will use the terms interchangeably in the following 
section. The legal framework for informed consent was crafted initially for 
clinical care exclusively rather than research. With regard to consent the law is 
clear about the duty of a doctor to inform patients and obtain their consent 
(Veriava, 2004). Injury to the patient as a result of not explaining to the patient 
the risks of the intervention may result in the doctor being sued for damages 
and financial compensation may have to be awarded to the patient.  
 
In South Africa, a failure to obtain consent can be treated as amongst other 
liabilities as negligence. From the legal perspective consent is invalid if any 
information is withheld that might be considered material to the decision to give 
consent (Classen & Verschoor, 1992:62-67). 
 
From a legal perspective, the idea of obtaining valid consent was to ensure 
another course of action was possible in cases of poor outcome e.g. when 
negligence by a doctor in treatment of his/her patient could be established. In 
the case of Fortner v Koch (1935), the USA Supreme Court reiterated the fact 
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that human experimentation must rest on “knowledge and consent” (Katz  
1987:3-5 ). Some legal scholars have argued that adequate disclosure of 
information is a necessary prerequisite to enable for valid consent (see, for 
example Rynning 1994).  In South Africa, in the case of Castell v De Greef 
(1994), the reasonable standard of information necessary for consent to be 
informed was identified.  Concerning the issue of obtaining informed consent 
and voluntarism to participate or withdraw from research, Singh and Ngwena 
discuss its legal sanction in their 2001 article.  
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CHAPTER 3: Legal and Ethical Documents Supporting Informed 
Consent & Good Research Activities with a Focus on the South 
African Particular  
 
In South Africa, the Bills of Rights as enshrined in Chapter 2 of the Constitution 
Act 108(1996) as well as the National Health Act 61(2003) are categorical about 
obtaining informed consent in human research. It must not be forgotten that 
what trumps law is the moral insight into the informed consent process. 
Therefore, the deontological – utilitarian - principlism and legal approaches to 
informed consent may be perceived as guiding tools in the application of the 
informed consent process. 
 
International Codes and Regulations and Informed Consent  
 
Where research involves the use of human beings, it is crucial to have codes 
and regulations that have as their objective safeguarding the safety and the 
dignity of the participants. This need was prompted by the atrocities committed 
during World War II.  Emanating from concerns of these violations it became 
clear that conditions for experimentation on human beings need to be well 
defined. According to Pedrini & PImple (2001), 
 
All modern codes of ethics concerning research, on 
human subjects, affirm the moral importance of informed 
consent.  
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International, and National codes and regulations are crucial in guiding 
researchers concerning their roles in and the importance of obtaining informed 
consent from research participants. If the guidelines are unclear, they are prone 
to be misused or applied incorrectly. The two most important international 
guidelines which are considered applicable in the context of research 
sponsored by developed countries and conducted in developing countries are 
the Declaration of Helsinki and CIOMS guidelines. 
 
Nuremberg Code 1947 
 
The historical impetus towards a research ethics was as a result of the atrocities 
carried out during medical research in German concentration camps during the 
Third Reich. Prisoners were used as guinea pigs by the Nazi’s for so-called 
scientific medical experiments. Many of these experiments were conducted to 
allegedly give the Nazi army beneficial information which would aid their troops 
in air and sea survival. Another aim was to experiment on prisoners to see if it 
was possible to make other ethnic groups similar to physical characteristics 
filling in with the ideology of the “Aryan master race” (such as experiments to 
see if eye colour could be changed). Because they were prisoners, all 
experimentation was conducted without the permission of any participants. As 
the extent of the atrocities was revealed, the result was the formation of the 
formulation of the Nuremberg Code. The first principle as the heading of The 
Nuremberg Code, (1947) states … [that] “The voluntary consent of human 
subjects is absolutely essential”.   
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This laid the foundation for the idea of consent and further elaborations moved 
to obtaining voluntary informed consent from research participants. The code 
further states that “This means the person involved should have the legal 
capacity to give consent.” The Code is categorical about the need for the 
participant to exercise free choice and to have sufficient understanding of the 
research in terms of type duration and purpose. The legalist approach is 
dominant in this Code as it was formulated by judges and should have been 
considered legally binding.   
 
That the Nuremberg Code is not legally binding was abundantly clear in 
Moreno’s (2001:343-356) description of the USA’s Pentagon’s attempt to 
circumvent the Nuremberg Code as early as the1950s. This is because 
Pentagon was motivating for soldiers and prisoners to be used for human 
experimentations. The Declaration and the guidelines arguably were seen as a 
hindrance because of their insistence of obtaining informed consent. This lack 
of obtaining informed consent by doctors is typified by further events that 
occurred in Jewish Chronic Disease Hospital (1963) and in the Willowbrook 
Hospital (1956-1970) cases where parents were said to have “consented “to 
having their children injected with hepatitis under the guise of a vaccination 
program.” One of the most infamous cases of failure to obtain informed consent 
(particularly in as the participants were not informed of an available drug which 
could offer cure, were the Tuskegee Syphilis Studies which ran from 1932 -
1972. 
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Following close on the heels of the Nuremberg Code, subsequent codes and 
regulations incorporated an informed consent ethos at various levels. According 
to Perley, Fluss, Zbigniew& Simon (1992:149-173), 
 
… the [Nuremberg] Code influenced the development of 
codes and guidelines, both in the general field of medical 
ethics and, more specifically, in the field of human 
experimentation. 
 
But despite the flurry of codes and guideline documents Faden,Lederer & 
Moreno.(2003: 1667-1671) state that between1948-1960 the popular press 
“was uncritical about experimentation on humans and assumed that those 
involved had freely volunteered to participate” .The assumption was that these 
atrocities could have only happened in totalitarian countries and not in 
democratic countries e.g. the USA. However, this complacently was shattered in 
a publication by Beecher (1966) which revealed that for many years, there were 
multiple instances where obtaining informed consent was superficially obtained 
or in many instances not obtained by researchers in human clinical trials.  
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The World Medical Association Declaration of Helsinki. (DOH). First 
document 1964) – DOH October 2008. Ethical Principles for Medical 
Research Involving Human Subjects  
 
The World Medical Associations’ Declaration of Helsinki (WMA, October, 2008) 
was the first document that was formulated by medical doctors in 1963. It laid 
the foundation for obtaining informed consent for research purposes.  As its 
purpose it stated, “Recommendations guiding physicians in biomedical research 
involving human subject”. The declaration was amended in 1975, 1983, 1989, 
1996, 2000, 2002, 2004, the latter two added notes of clarifications in certain 
paragraphs culminating in what is termed the “DoH/Oct 2008” document. 
Principles 24, 25,26,27,28 of the Declaration deal with informed consent at 
length. Of importance is that both principle 9 of the DOH 1964 and principle 24 
of 2008 emphasize the elements of information to impart to the participants. 
These elements include the aims, methods, anticipated benefits and harms. 
The principles stress the importance of voluntary participation and a choice to 
withdraw from the study should be emphasized in the information to be 
imparted. Furthermore, both Declarations allow for proxy consent in clinical 
trials for those who are unable to give consent. According to (Schuklenk, 
2000:969-977) “proxy consent was introduced by stealth in these guidelines 
written by doctors for themselves.” This document is not legally binding in 
international law. But it places moral obligations on researchers to obtain 
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The Council for International Organizations   of Medical Sciences (CIOMS), 
International Ethical Guidelines for Biomedical Research Involving Human 
Subjects in collaboration with the World Health Organization (WHO) 2002  
 
The (CIOMS) Council for International Organizations and Medical Sciences:, 
2002), in collaboration with the World Health Organization (WHO) prepared the 
Ethical Guidelines for Biomedical Research on Human Involving Human 
Subjects. These guidelines have also had several amendments since 1993. 
Besides the requirements of informed consent, the guidelines stress the 
importance of protection of vulnerable groups in research, the guidelines are 
accompanied by commentary which describes who the vulnerable groups are. 
(Tangwa, 2004:63-67) is of the view that ethical guidelines drawn from the 
Western perspective “were basically attempts to universalize and globalize a 
particular powerful paradigm, Western paradigm”. He further urges 
inclusiveness in crafting international guidelines. By this, he implies that there 
has not been adequate inclusiveness of expertise from the developing regions 
where the international guidelines have been compiled thereby questioning 
whether these documents are truly international and if so by whose standards. 
Bhutta (2004:771-776) believes current guidelines need revision as they lack 
clarity in terms of the consent process research in developing countries. 
However, because both the Declaration of Helsinki and CIOMS guidelines are 
not legally binding, perhaps this could explain why the US Food and Drug 
Agency (FDA), at least according to Camporesi (2008),  does not regard them 
as credible.  
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The World Health Organization’s (WHO) Guidelines for Good Clinical 
Practice (GCP) on Trials of Pharmaceutical Products 
 
Clause 3.3 of the World Health Organization’s Technical Report (1995) 
reiterates the Declaration of Helsinki and CIOMS guidelines on informed 
consent stressing the issue of how information to the participant should be 
presented about trials, and that “no subject should be obliged to participate in 
the trial”. Of importance concerning the guidelines is that of taking cognizance 
of safeguarding those participants who are subordinates to their superiors – in 
other words, the protection of vulnerable groups. 
 
Ethical considerations in HIV Preventive Vaccine Research - UNAIDS 
Guidance Document 2000 
 
Guidance Point 12 of the document says “Independent and informed consent   
based on complete accurate and appropriately conveyed information should be 
obtained from each individual …” (UNAIDS, 2000).  What is of interest about the 
document is that it stresses the fact that informed consent is a two stage 
process e.g. pre-trial screening for eligibility and second stage once a person 
fulfils the criteria for inclusion in the trial as a participant.  
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Operational Guidelines for Ethics Committees that Review Biomedical 
Research 2000  
 
This is the WHO supportive document for review committees. On the issue of 
informed consent the World Health Organization (2000) guideline stresses that 
“a full description of the process for obtaining informed consent, including the 
identification of those responsible for obtaining consent is necessary”.  This puts 
an onus on the research ethics committees to ensure that informed consent is 
obtained legitimately by the researcher and that solely responsible for it. 
The international guidelines appear to be comprehensive in addressing 
informed consent in research in terms of scope and content. Granted; they are 
not cast in stone as they can be amended to suit any unforeseen circumstances 
that arise. The principles however would remain unchanged. It would be the 
application of the principles that would be altered. Yet despite this, these 
international guidelines are not fully applicable to the developing world context.  
However, the importance of international guidelines is nevertheless to ensure 
that the requirement for informed consent is well entrenched in the minds of 
research communities worldwide/ Moreover, they serve to signal that at no point 
in the research process should the practice of obtaining informed consent from 
research participants be just an option, to accept or reject, and this remains true 
in both the developed and the developing world contexts. 
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National Guidelines in South Africa 
 
Many developing countries especially in Africa are signatories to international 
codes and declarations by way of membership for example, the WHO, the UN, 
the  African Union, SADAC and many other organizations that espouse the 
values of ethics in research.  In addition, many professionals in developing 
countries are aligned to health care associations and research entities whose 
scientists are affiliated to international institutions and organizations whose 
philosophy is to adhere to the ethical values for conducting research. 
 
From the literature, it is obvious in African countries, the incorporation of 
informed consent in the legislative framework for research purposes is sparse 
resulting in some instances of unethical research activities partially due to lack 
of or weak legislative controls (Bazara, 1998:625-626).This is also echoed by 
Chima (2006:858-852) who observed the circumvention of international 
regulations and codes by researchers whilst conducting research in developing 
countries.. Informed consent for example was not obtained by Pfizer during the 
trials of Trovafloxacin® in Nigeria (Hensey, 2003). This could be attributed to 
both a lack of a strong legislative framework and the ease in which international 
rules and codes can be ignored in developing countries. Added to this, there are 
weaknesses of research proposal oversight at local and national levels by 
research ethics committees and councils. In addition, these countries are home 
to large numbers of vulnerable populations who have little or no knowledge of 
their rights in the research setting and are probably unaware of the courts as a 
legitimate recourse. It is clear that laws promulgated at national levels on 
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obtaining informed consent aid in enforcing compliance especially where 
international or multi site research is envisaged and the probability of harm to 
research participants a real possibility. 
 
South Africa and the Assurance of Informed Consent   
 
South Africa has one of the most progressive Constitutions in the world. At its 
core is the protection of the dignity of all persons.  The ushering in of 
democracy in 1994 brought with it a window of opportunity to institute stringent 
conditions for doing research. The revelation of Dr Bason’s experiments during 
the Truth and Reconciliation Commission hearings gave further impetus to 
address the issues of experiments on human participants.  An example of note 
is the 1967-1999 “Aversion Projects”, which were experiments conducted for 
“sexual alignment” by doctors on White male gay army recruits, of ages ranging 
from 16-24years (Simo, 2000). Here there was a flagrant disregard for the 
international guidelines. Of note, South Africa was a member of the World 
Medical Association at that time. 
 
Chapter 2 of the Bill of Rights (BORS) of the of the Constitution (Act no 
108 of 1996) 
 
Chapter 2 of the Bill of Rights (BORS) of the Constitution (Act no 108 of 1996) 
in Section 10 affirms the need for respect and protection of peoples’ dignity. 
This clause clearly is in keeping with the ethical principle of respect for persons / 
autonomy. For, example, Section 12(2) states that; 
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 “Everyone has the right to bodily and psychological integrity” which includes the 
right-  
a)  12.2(a) to make decisions concerning reproduction. 
b)  12.2 (b) to security in and control over their body, and 
c) 12.2(c) not to be subjected to medical and scientific experiments without 
informed consent.” 
 
While Section 36 of the BORS limits all rights on condition the limitation is 
reasonable and justifiable in an open and democratic society, it is highly unlikely 
that an argument to limit the right to informed consent in research would be 
successful 
 
The National Health Act (NHA) 2003 (Act no 61 of 2003) 
 
Section71.1 of Chapter 9 in The National Health Act (No 61 of 2003) deals with 
human experimentation. Section 71.1 lays down the conditions for 
experimentation or research on human subjects as follows;  
a) Section 71.1 (1b) “with written consent of the person after he or she has 
been informed on the objects of the research or experimentation and any 
possible or negative consequences on his or her health.” 
Section 71.2 explains under which conditions minors may be involved in 
therapeutic research as follows; 
b) 71.2 (a) “if it is in the best interest of the minor” 
c) 71.2 (b) “in such manner and on such conditions as may be prescribed 
d) 71.2 (c) with consent of the parent or guardian of the child “ and 
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e)  71.2(d) “if the minor is capable of understanding, with the consent of the 
minor.” 
If the research is conducted for non therapeutic on minors the follow should 
apply;  
a) Section 71.3(a) (i) “in such manner and on such conditions as may be 
prescribed; 
b)  Section 71.3 (a) (ii) “with the consent of the Minister,”  
c) 71.3. (a) (iii) “with the consent of the   parent or guardian of the minor;”  
d)  71.3. (a) (iv) “if the minor is capable of understanding the information, the 
consent of the minor”. 
Section 71.3.b states the conditions under which the minister may not give 
consent as follows; 
a)  Section 71.3.b. (i) “the objects of the research or experimentation can 
also be achieved if it conducted on an adult.” 
b) 71.3.b. (ii) “”the research or the experimentation is not likely to 
significantly improve scientific understanding of the minor’s condition , 
disease or disorder to such an extent that it will result in significant 
benefit to the minor or other minors;  
c) 71.3.b (iii) “the reasons for the consent to the research or 
experimentation by the parent or guardian and, if applicable,  the minor 
are contrary to the public policy;” 
d) 71.3.b(iv) “the research or experimentation poses significant risk to the 
health or  well being of the minor or;” 
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e) 71.3.b(v) “there is some risk to the health or well being of the minor and 
the potential benefit of the research or experimentation does not 
significantly outweigh that risk.” 
 
Should Section 71 be promulgated, it will go a long way in ensuring that 
researchers not only have an ethical responsibility to obtain informed consent 
from research participants but also a legal responsibility.  In the interpretation of 
the NHA it is clear that the RSA law recognizes obtaining informed consent as 
pivotal to the research process.  
 
 Department of Health (DoH):  DoH Guidelines for Good Clinical Practice in 
the Conduct of Clinical Trials with Human Participants in South Africa 
(2006 Second Edition)  
 
The South African DoH provides two main guidelines for researchers. These are 
Good Clinical Practice (GCP) guidelines which were first published in 2000 
(revised in 2006) and the Ethics in Health Research: Principles, Structures and 
Processes, the specific ethics guidelines for health research in the country.  
 
What these guidelines state is that, “informed consent is an essential 
component of ethical research” (DoH, 2006). Implicitly, this means research 
done without informed consent is unethical. The main strength of the guidelines 
lies in the acknowledgment of the context of developing countries like South 
Africa which is characterised by people coming from disadvantaged and 
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vulnerable communities. The guidelines are categorical that especially from 
vulnerable populations informed consent should be obtained.  
 
The GCP guidelines direct researchers to use “culturally acceptable practices 
including the use of the participant’s language of choice” (2006:11). This is 
aimed to highlight that participants understand the information given to them. 
The importance of this document is its power to lay down clear conditions of 
obtaining informed consent from a context where there could be barriers e.g. in 
language, culture, and socio-economic differences. The document also echoes 
the health rights and law perceptive embedded in the Constitution of the 
Republic of South Africa (1996) in section 27 which guarantees the right to have 
access to health care services. What is of interest is that it stays clear of 
communitarian directives in that it does not mention how to obtain  and the 
conditions of obtaining what is called “community consent”.  
 
Ethics in Health Research: Principles, Structures and Processes (PSP 
2004) 
 
The DoH (PSP) document allows the carrying out of research in an emergency 
situation but initial permission must be sought from a Research Ethics 
Committee (REC) or the Head of Department (HOD) of the emergency facility. 
The REC or the HOD must ensure that; 
a. “Justification for carrying out the research is sound  
b.   Cultural and religious sensitivities of the participant have been taken 
into consideration 
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c. It has been established   that  the participant cannot give consent 
d. Research has a potential of being therapeutic and does not pose more 
than the acceptable risk  
e. A legal representative would be told if the research has been done and 
opting out of the research was optional.”   
 
If the participant recovers he/she will be told about the research that has been 
carried and that the right to withdraw will be guaranteed. These conditions 
ensure that emergency research is not used as a tool to exploit participants. In 
such situations deferred consent is ethically acceptable   
 
The incompetent participant lacks that psychological maturity to understand and 
communicate preferences in a coherent manner and this is also an ethical 
challenge. The challenges are that such a person cannot make rational 
decisions and therefore from such a person informed consent cannot be 
obtained. Those who fall under this category are e.g. the very young and the 
elderly.  Informed consent should be obtained from a competent adult on behalf 
of the participant but after the informed consent process is followed. 
 
Covert research relates to research that could not be done without deceiving or 
hiding the purpose of research from participants. Deception research while 
sometimes necessary is in the main unethical   The PSP document by DoH 
however has laid conditions for this action as long as the REC is satisfied that;  
a. “The validity of the research would be compromised if there was no 
concealment.  
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b. There are strict and well understood limits to the deception. 
c. The only way to gather information is by use of deception methodology, 
d. Participants are not exposed to higher than the minimum risks 
participants will be debriefed after the fact.  
e. Participants could withdraw the data about themselves after the 
research has been completed and  
f.   Finally that the relationship will not be soured between the researchers 
and the participants after the research”.  
 
Many questions are raised by these conditions for deception research stated 
above including whether it is morally correct to do convert research as it 
conflicts with ethical norms governing research on human participants.  
 
The pros are that the researcher may discover information which he /or she may 
not have discovered if the research was done in an open manner, due to 
unavoidable bias if the participant was aware of all details.  The cons are that 
firstly, it is not ethically sound as it shows no respect for persons.  Misleading 
participants or not divulging all information about the purpose of the research is 
ethically very difficult to defend and can be seen as using the participants as a 
“means to an end “. Once people discover that deception was used to carry out 
the research, they might show antipathy against future researchers. In addition, 
it does not give participants the chance to ask pertinent questions as the 
researcher hides information from the participants.    
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The PSP (2004:4) guideline states that “informed consent must be obtained 
from participants before the research can begin”. Both written and verbal 
informed consent must be obtained, unless there are good reasons to the 
contrary, such as a situation of coma, emergency, or mental incapacity (DoH  
2004: Sections 5.9 & 5.14)  The guidelines entrenches  the oversight role of 
RECs concerning the assurance that informed consent requirements are 
included in the protocol. It is a generic document for all types of research. The 
Good Clinical Practice (GCP) document reemphasizes the importance of 
obtaining informed consent even from the vulnerable communities.   
 
These guidelines have also incorporated the National Health Act (Act 61 of 
2003 Section 68) which outlines guidelines on the use of human tissue samples 
where it states when consent is required and the requirement concerning when 
consent can waived.    
 
The South African Medical Research Council (MRC): Guidelines on Ethics 
in Medical Research: General Principles: Book 1 2005 
 
Book 1, Section 5 of the 2005 guidelines produced by South African Medical 
Research Council (MRC) is titled The Legal and Moral Justification for 
Research. The MRC guidelines basically reiterate the elements of informed 
consent in their previous documents.  Sub section 5.3.1 states, “Consent must 
be given by someone who is legally and factually capable of consenting.” The 
document further distinguishes competence from the perspectives of adults and 
minors.  What is of interest is that the document tends to take a more legalistic 
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outlook on issues of capacity. The MRC while given much respect, does not 
have the legal standing that DoH guidelines have, this is because DoH 
guidelines are a response to the National Health Act.    
 
 
Health Professions Council of South Africa (HPCSA)  
 
The HPSCA is the statutory body established under the Health Professions Act 
No 56 of 1974, which registers doctors, dentists and other allied health care 
workers.  It was formulated to protect the public from unethical behaviour by 
practitioners amongst other functions. Booklet 9 on Informed Consent of 
HPCSA (2007:1) states the following,  
 
Patients must be given sufficient information in a way that 
they can understand, to enable them to exercise their right to 
make informed decisions about their care. This is what is 
meant by an “informed consent.  
 
In Section 4 of the same booklet it is stated that “patients should have 
knowledge and understanding of the harms or risks; appreciate and understand 
the nature of harm and risks; have consented to the harm or assumed risks and 
that the consent must have been comprehensive” (ibid:5 ).  
 
Researchers involved in biotechnology such as gene mapping, DNA 
sequencing, diagnostics, cloning and genetic modification also have particular 
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duties. It is for this reason that the HPCSA developed General Ethical 
Guidelines for Biotechnology Research 2007 Booklet 7. Section 2 of the booklet 
reiterates the importance for the researchers to abide by the four principles of 
biomedical ethics. In addition, the value of integrity is promoted for all those 
engaged in research.  The principles grounding informed consent are reinforced 
in the ethical guidelines. The preamble of the section on informed consent 
states “It is necessary to obtain informed consent from the research participant 
prior to commencing research” (2007:11).  Sections 2.6.4 -2.6.4.4.2 deal with 
the issue of informed consent in adults, mentally ill or handicapped, elderly, 
pregnant women, the unconscious patients, the dying, minors and children. For 
each of these groups’ conditions for obtaining informed consent is spelled out.  
 
Patients’ Rights Charter (2000) 
Although this document addresses itself to health care its scope is wide enough 
to   address issues of research as most health research is conducted in health 
facilities. Concerning informed consent the Patients’Rights Charter states 
Everyone has the right to be given full and accurate 
information about the nature of one's illnesses, diagnostic 
procedures, the proposed treatment and the costs involved, 
for one to make a decision that affects anyone of these 
elements. (2000:2)   
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On choices, it states that,  
Everyone has the right to choose a particular health care 
provider for services or a particular health facility for treatment 
provided that such choice shall not be contrary to the ethical 
standards applicable to such health care providers or facilities, 
and the choice of facilities in line with prescribed service 
delivery guide lines(ibid:2).  
This document is rights-centred as it was envisaged to affirm patients’’ right to 
access to healthcare services. Amongst the roles and responsibilities of patients 
one that is pertinent to this paper is the patient’s responsibility, specifically “to 
respect the rights of other patients and health providers”. 
 
Research Ethics Committees and the National Health Act, 2003 (Act No. 61 
of 2003)   
 
It is an accepted international practice that research involving human 
participants should be conducted only after thorough reviews have been carried 
out by RECs. In many countries, RECs are called Institutional Review Boards 
(IRB). In the following section, I will use the terms synonymously.   
 
Reviews by RECs are guided by international, national and institutional 
research guidelines. Their roles, amongst others, include review of the research 
proposals for risks, benefits, and overall the protection of research participants. 
In addition to this, REC’s have the responsibility of educating and assisting 
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researchers concerning the ethics of research, monitoring research and to 
provide accountability to the public.  Overall, the key role of the REC according 
to Dhai (2005:595-59) “is to safeguard the dignity, rights, safety and well being 
of all participants in human research subjects. Implicit in this is to scrutinise the 
informed consent documents and processes for its appropriateness, and 
protection of participants’ integrity”.   
 
Some of the conditions which developed countries must take cognizant of are 
under scored by (Cleaton-Jones  2005:267-269 ) “functioning of IRB……., in a 
developing country environment requires knowledge of local culture, resources 
and services”. This is not always understood nor accepted by RECs and 
researchers who operate in resource–rich environments. Ideally, a REC should 
be constituted of members who have the ability and the expertise to recognize 
the gaps in the protocol and in the consent form.   
 
Attention to the lack of capacity and infrastructure in developing countries to 
review protocols is an important point raised by Kass et al (2005). Lack of 
capacity could result in not examining the consent forms properly during the 
research ethics committee sittings. This thought relates to the ability of a REC to 
have a good mixture of people who have sufficient knowledge to review 
proposals for their scientific validity and ethical acceptability (WHO 2007).  One 
of the major criticisms of RECs at their current stage of development is that the 
membership may be socially and culturally removed from communities for which 
the protocols are being reviewed.  A way to overcome this is for RECs to invite 
community members and community advisory board representations to 
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meetings which involve participants from those particular communities are being 
discussed. 
 
It is commendable that although the main aim of the National Health Act (NHA) 
(Act No. 61 of 2003) is to ensure that everyone in South Africa   has access to 
heath care, part of the Act reiterates the necessity to establish research ethics 
committees in “institutions, health agencies, and health establishments where 
research is conducted” (see No 61, Chapter 9 Sections 73, 1 and 2).  This is 
because of the importance of research for the improvement of the population’s 
health. Of equal importance in the Act is the protection of research participants’ 
rights and dignity. Therefore, to ensure that the research is conducted ethically, 
ethical clearance for protocols must be issued by the research ethics 
committees after comprehensive and competent ethics review.  
 
Research conducted a few years ago by Moodley & Myer ( 2007) showed that 
membership in the RECs was not adequately diversified. There was variability 
in terms of capacity, operational systems and infrastructure. In addition to that 
their study also revealed that “previously advantaged universities seem to be 
faring better compared to the formerly historically disadvantaged institutions.”  
(It will be interesting to see what the situation is now especially since the 
National Health Research Council (NHREC]) has started registering RECs and 
will soon be auditing their processes.) 
Despite these concerns, there is a National Directive as to REC composition 
and functioning. Currently, twenty RECs have been registered with the NHREC; 
two of them are private RECs (Dhai, Personal communication 2009). Just how 
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these function, is not known, making it much harder to assess their capacity 
especially on the issue of informed consent. According to van Bogaert 
(2007:240) the lack of political will to support and promote the value of 
provincial RECs is the major hurdle to their development. Until comprehensive 
audit and assessments are done, the effectiveness of these committees in 
ensuring informed consent may not be known.  
 
Overall, South Africa has strived to produce world class guidelines for 
conducting research in an ethical manner. These guidelines are unequivocal on 
issues of informed consent.  Of importance is the legal framework in buttressing 
the guidelines by articulating the conditions of obtaining informed consent. But 
what remains doubtful is the capacity of the many research ethics committees to 
play their roles effectively as an enforcing arm. It is hoped that as more 
opportunities open up locally to train health professionals in bioethics and 
research ethics, capacity will gradually be built to include them into RECs 
functioning. However, it must be emphasized that guidelines rules and codes 
are only one part of the matter-the monitoring of research and education of 
research participants concerning their role is vitally important.  
 
This chapter explained how informed consent has been incorporated in 
international guidelines and the conditions under informed consent should be 
applied in research. It has further demonstrated that a developing country like 
South Africa views the obtaining of informed consent as a precondition prior and 
during the research process. These are principles enunciated not only in the 
codes and guidelines but also in the law. 
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CHAPTER 4:  Informed Consent in Research: An Ethical, Legal 
& Cultural Commentary  
 
The value of informed consent has already been detailed from the ethical 
perspective in the last chapter as that of respect for persons and of enabling 
autonomy and allowing autonomous decision making in competent participants 
in research. 
 
There are other additional ethical arguments supporting informed consent. For 
example, it can be argued that obtaining informed consent could have 
secondary positive ramifications.  One of them is that of establishing a platform 
for a researcher-participant relationship based on mutual respect. Such a 
relationship is characterised by transparency trust, accountability and 
communication.  By communicating in a transparent manner about the aims of 
the research and risks and probably potential and mutual benefits, mutual 
respect and trust is built paving the way for an ethical informed consent 
process.  According to Wear (1993: 100-112) this can also result in a reduction 
of psychological distance whereby the participant and researcher see each 
other as moral beings. Accordingly, each other would be seen as equals and 
any benefits gained would also be seen as mutual. These mutual benefits 
should be seen in the light of a give and take relationship in that research 
participants voluntarily sacrifice their time to participate in the research while the 
researcher gains experience and knowledge. The research participants, by 
giving, ought therefore to benefit, either directly or indirectly as a result of 
involvement in the research. 
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Open and truthful communication also encourages participation in discussions 
thus reducing misconception about each other as well. Common in developing 
countries, therapeutic misconception, especially in clinical trials, may also be 
avoided through a properly executed informed consent as many of participant 
preconceptions would be clarified. Therapeutic misconception occurs when a 
trial participant misconstrues the purpose the research as therapy. It is therefore 
important for the researcher to explain to the participant that he or she is in a 
state of equipoise in order to prevent therapeutic misconception. Equipoise, 
according to Freedman (1987: 141-145  ) is  
 
... a state of genuine uncertainty on the part of the clinical 
investigator regarding the comparative therapeutic merits 
of each arm in a trial.  
 
Informed consent also ensures that privacy is protected from unwanted and 
unsolicited physical or psychological intrusion. According to White & Zimbelman 
(1998:477-499) informed consent “can serve as foil to culturally or 
professionally embedded values and practices that undercut patients’ values 
and goals”. By that I understand they mean informed consent is a protective 
mechanism against health workers’ prejudices which include a belief that by 
virtue of being professionals their culture is superior to that of patients.  
Although they were writing about clinical care, this is also apt for contemporary 
research endeavours.  
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Researchers in many instances meet social values and cultural beliefs that are 
different from theirs for the first time during the research process in developing 
countries. Much has to be done by these researchers prior to conducting the 
research. Researchers need to develop collaborative partnerships with 
communities and potential participants from the onset. . This would serve as the 
entry point of the informed consent process, as discussing and raising 
awareness of the communities’ burdens and benefits is pivotal for ethically 
conducted research. Raising awareness, understanding and respecting 
community culture, traditions, and sensitivities, will result in facilitating the 
recruitment and enrolment process. Moreover, it will assist with compliance, and 
retention of participants in the research. If practiced, application of this process 
will serve to circumvent the high attrition rates in the context of poor 
understanding.  
 
When informed consent is treated truly as a process, commencing from the time 
of community consultation prior to the actual research and continuing into the 
research where the principle of respect for persons is consistently upheld, 
exploitation and manipulation of research participants may be circumvented.  
These are some of the ethical perspectives which are part of the research 
process.  
 
Concerning law, informed consent, according to Montange ( 1974: 1632-1664) 
came about as a result of medical malpractice where a doctor gave treatment to 
a patient without consent. Because this case involved touching a patient’s body 
without valid consent it was regarded in the court of law as “battery”. The case 
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of Pratt v Davies (1905) tells of the case of a Dr Pratt who performed a 
hysterectomy on Mrs Davis to cure her of epilepsy. Of importance of the case 
(as it would be considered medically suspicious by modern standards) is that Dr 
Pratt intentionally deceived Mrs Davis concerning the nature of the treatment he 
would perform. This was because the medical doctor simply wanted the 
patient’s cooperation to perform the operation. The case confirmed that consent 
includes the legal (and ethical) concept of fidelity.   
 
The importance of disclosing risks associated with an intervention was also 
clearly shown in the landmark case of Canterbury v Spence (1972). In this case, 
Dr Spence operated on Mr. Canterbury to repair his spinal defect. But the 
doctor failed to explain in full the risks associated with the surgery. This case 
confirmed the need to impart information including risks that a reasonable 
prudent patient would consider relevant in giving consent to a procedure. 
Informed consent from the legal perspective serves as a protective mechanism 
against illegal bodily invasion.  
 
Amongst its other functions, consent, according to Schuck (1994:899-959) 
defines the law of contract. At its core is respecting ones dignity to make 
informed consent and choices. This implies therefore that fiduciary duties are 
owed to the research participant. This is particularly important in the 
globalisation of research where most funding is from international consortiums 
with the likelihood that although research is being carried out in developing 
countries the benefits may accrue which mainly advantage developed countries.  
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Regarding South Africa, the legal arguments in Chapter 2 of this research report 
emphasise the legal responsibilities concerning informed consent in detail. 
Based on the arguments stated above one would imagine that there is an 
agreement amongst researchers that informed consent should be obtained at 
all costs and in every situation from competent persons before any type 
research can be carried out.  
 
However, there is a growing amount of literature to suggest that there are   
circumstances and contexts that dictate flexibility and should be considered.  It 
is argued that in many cases it is not only unreasonable but also not germane. 
Defending such arguments, points are made about the questionable 
‘universality’ of application of informed consent in the current manner as 
suggested in the international guidelines. This is because the context in which 
the research takes place reflects different worldviews, ways of life, perspectives 
and outlook. This is not to say that the process of informed consent is totally 
negated, it is to say that some arguments are given for greater flexibility in the 
informed consent process for various reasons. 
 
There are views that reflect paternalistic and pseudo anthropological 
perspectives   on the issue of research participants in developing countries.  
This is based on the assumption that the researchers know the needs of the-
would-be-participant. This knowledge is based on superior knowledge about the 
research process coupled with an understanding the prospective participants’ 
worldviews.  Some further argue that   insistence on strict criteria of seeking 
informed consent retards scientific progress as research participants just cannot 
53 
 
 
 
 
grasp the technical information given. There has been also an 
acknowledgement by Macklin (2004), a strong proponent for autonomy, of the 
need to adjust the process of obtaining informed consent in response to local 
level needs. However, Gostin (1995:844-845) cautions against deviations from 
prescribed standards set for obtaining informed consent.   
 
Some skeptics harp on the fact that the allure of better health care (a coercion 
factor) is the driving force behind the participation in research amongst poverty 
stricken communities. It would follow that as autonomous decision making is 
compromised, so is informed consent. Additionally, it is argued that participants 
may not understand the research jargon like “placebo” as there may not be an 
equivalent term in their particular vernacular.  
 
Critical to obtaining IC therefore is the ability of the researcher to understand 
the educational, linguistic, social and cultural backgrounds of the participants in 
order to communicate clearly. Researchers need to learn from communities in 
order to build in culturally appropriate research designs which take care of 
ethically appropriate principles.  
 
What is proposed is of paramount importance - to have the safety of 
participants   safeguarded - without the stringency of the informed consent 
process.   Some have gone as far as rejecting the bureaucratic procedures 
involved in informed consent stating that that processes of informed consent are 
social constructs which are not in keeping with social changes. A point is also 
raised that one should consider that  consent practices developed in early 
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twentieth century are not perceived as having the same meaning in the early 
twenty first century.  From these perspectives; another view which is important 
comes from that of culture.  
 
Culture and Informed Consent  
 
A topical debate is that of the confluence of culture and the obtaining of 
informed consent in developing countries in non-intrusive ways that are ethically 
acceptable. In this perspective, because autonomy is relative and viewed as a 
social construct, the  consent practises developed for individualistic Western 
societies may be cultural inappropriate and therefore is not applicable especially 
in some communitarian cultures. This is because autonomy and its limits are 
determined by the will of the community.  
 
The criticism emerged because of wholesale application of informed consent 
based on a Western construct upon developing countries. Because, it is argued, 
autonomy is a Western concept which stresses individualism it is an anathema 
to communitarian self-identity in traditional developing countries like Africa. The 
debate intrinsically implies that the configuration of the informed consent 
process in the current form is not a universally applicable concept.  
 
African philosophers have argued that it is fallacy to equate communitarian 
consent as divorced from individual consent just because informed consent has 
a multi step process is a mistake. Some have criticised the focusing on 
autonomy alone, which is a norm in Western cultures. The suggestion is that 
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there should be a considered effort by “Westerners” to understand and embrace 
the cross cultural context where     each person sees him or herself in relation to 
others.  Mansoh (2008:  104-114 ) contends that “ … Acting within the contexts 
of cultural norms and institutions does not by itself imply lost, diminished or 
compromised rights of autonomy and self determination”.  He defends this 
statement by giving an example of how even in the West that a researcher 
wishing to conduct research in an institution would need permission from the 
authority of that institution. From a principlist point of view he sees this more no 
different than seeking community consent.   
 
My argument however is that generally, African cultures are gradually loosing 
homogeneity and societal changes within communities have gradually shifted 
the ethos of decision making to be more participatory. This change includes 
autonomous decision making. Hence, the obtaining of individual informed 
consent versus communitarian consent is gradually taking root. As an example, 
the HIV / AIDS pandemic has clearly demonstrated that individuals will make 
autonomous decisions about participating in research regardless of so-called 
communitarian bonds. I argue that although community consent is required, one 
cannot ignore the importance of respect for individual consent. Perhaps, when it 
comes to the community aspect of the process, “permission” as opposed to 
“consent” terminology, should be used. 
 
The debate is strengthened further, it is argued, by the fact that in some 
cultures decision making is often deferred to family members, the elders, chiefs 
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or religious leaders. Therefore, it is sometimes assumed that individual self-
determination is null and void.  
 
A cursory examination of the reasons that dictate exceptions in obtaining of 
informed consent is admittedly tempting and indeed may have value. However, 
closer scrutiny yields pitfalls because they do not admit that cultures always 
change and negate (for right or wrong) the effects of globalization. For those 
engaged in REC processes, a major concern is that if current guidelines and 
codes are modified, greater avenues are opened for unscrupulous research to 
take place which will cause great harm to vulnerable populations. .  
 
The scientific quest for knowledge should not trump respect for persons. It is 
possible to explain information in simple ways that allow ordinary people to 
understand medical and scientific jargon. Doing so has the potential to 
empower research participants to make truly informed decisions. Although it 
may appear that the bureaucracy is overwhelming, they are necessary to 
ensure that informed consent is obtained for the protection of research 
participants. Bureaucracy in this instance refers to e.g. oversight of research 
ethics committees regarding the standard of the information sheet for obtaining 
informed consent (Farham & Bradbury 2000 ). The danger of ignoring the 
bureaucracy has been shown to have done harm to research participants.  
 
As examples, one may point to the recent South African case where Professor 
Werner Bezwoda subjected patients in his clinical trials to inappropriate 
research protocols without their informed consent and without the knowledge of 
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the University of the Witwatersrand. At a 1999 international conference, 
Bezwoda claimed he had successfully treated breast cancer patients with very 
high doses of chemotherapy. He claimed that these high doses, combined with 
bone marrow transplant on women with high risk breast cancer, resulted in 
lower remissions and lessened morbidity. International experts on breast cancer 
showed great interest in the studies and came to South Africa to verify his data. 
It then transpired that he had falsified his data. Of interest is that many patients 
were Black and had not given their consent to be in the trial.   
 
Pfizer is another example case of an international company that conducted 
unethical clinical trials in 1996 by administering Trovan© which was not 
approved by the (US) Federal Drug Administration (FDA) in an oral form for 
paediatric use.  The drug was administered to Nigerian children with 
meningococcal meningitis without their parents’ consent. Some of these 
children died. While permission to conduct the drug trial was allegedly given, 
after years of court disputes Pfizer eventually compensated the families of the 
victims (Howden, 2009). The ethical issues include that of REC approval or not, 
informed consent or not, and importantly the clinical testing of a non-FDA 
approved oral form of a drug in an emergency situation on a vulnerable 
population. 
 
In both cases, it appears that bureaucracy was circumvented by the 
researchers. It also appears that it was no accident that these occurred in 
developing countries.   It is also critical in this fast-changing world where 
exchanging of data is fast and highly sophisticated, that human tissues can be 
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sold to the highest bidder without the informed consent of the participants. It is 
also doubtful that the processes for   obtaining informed consent developed in 
early twentieth century really have a radically different meaning in the early 
twenty-first century. A way forward is to have the processes enriched. Respect 
for persons as a concept is core to informed consent and respect for persons 
must remain a research ethics imperative to uphold.  
 
That being said, there are instances when it is ethically acceptable to 
circumvent the informed consent process. Some examples include emergency 
situations, or when the identified participant is incompetent to directly give 
consent because of age or mental incapacity (deferred consent). In the latter, 
however there are regulations concerning proxy consent which are applicable,  
 
These last two chapters have demonstrated that informed consent is 
extensively addressed in the international guidelines, coupled with national 
codes and guidelines. Guidelines are dynamic and may well change over time 
in response to changing circumstances. In addition there is general agreement 
that they are applicable even where the social environments are different. The 
main aim is to ensure that no one participates in any research without informed 
consent being obtained in order to fulfil the principle of respect for persons. 
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CHAPTER 5: Highlighting “Unfinished Business” in Informed 
Consent and Recommendations for Its Further Development 
 
“Unfinished Business” 
 
Is there an unfinished business in the obtaining of informed consent? What do I 
mean by the term “unfinished business?” In this paper I meant areas or gaps 
which, if not urgently remedied may ethically compromise the genuine obtaining 
of informed consent. 
 
At the beginning of this paper, I demonstrated that codes and guidelines 
concerning research involving human participants do incorporate the 
importance of obtaining informed consent. Moreover, many are quite detailed 
providing guidance on how to obtain informed consent whilst protecting 
communities regardless of their cultural differences. They are universal, making 
their application acceptable as respect for autonomy, in spite of material and 
social differences, is their prime goal.  
 
However guidelines are only a roadmap. This means that there must be 
properly constituted structures and effective mechanisms in place to ensure 
compliance. A major function of developing world RECs is to ensure that clinical 
/ medical research conducted in their countries adheres to the ethos of good 
research practices.  
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I now propose five broad categories under “unfinished business” which have the 
potential to threaten the obtaining of informed consent in developing countries. 
 
1) The Capacity and Training of Research Ethics Committees 
 
The capacity and training of research ethics committees in institutions and 
health establishments in many instances is not uniform in developing countries. 
Most research ethics committees conduct their business on a voluntary basis 
without payment. Members are recruited for their expertise in a particular field 
that does not necessarily reflect ethics training. As expected many of them are 
burdened by their own service delivery and may not necessarily have the skills 
to unpack or even see the nuances in the protocols to discern that the informed 
consent and other ethical issues are in danger of being infringed. The “publish 
or perish” culture in tertiary institutions has resulted in an increase in the 
number of protocols to be reviewed adding extra work to ethics committee. 
According to (Cleaton-Jones & Vorster, 2008:38-43)   “general research 
application increased from 439 to 553 in 2007” at the university of the 
Witwatersrand.  In addition, there is a high likelihood that committee members, if 
they are not properly trained, may be partial to colleagues held in highest 
esteem in the research arena. This could possibly result in the committee 
allowing infringements of ethics including informed consent processes. Training 
of Research Ethics Committees is important but it is not sufficient as institutions 
need to support their functioning which may include the employing of full time 
reviewers. It is imperative that the functioning of the committees need to be 
monitored by the National Research Ethics Councils through yearly reports. 
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2) Monitoring of Research Processes in the Field 
 
It is generally agreed that informed consent is a process which means it has to 
be instituted before the research process and reinforced during the research. 
This has a bearing on how informed consent should be monitored. The fact that 
there is a paucity of literature on the monitoring of informed consent, whether 
the process is actually continued throughout the research is a complex thought. 
The lack of information concerning monitoring may be due to the difficulty of 
observing the process on an ongoing basis during the conduct of the research. 
In addition, difficulties are also experienced because of the   need to uphold 
confidentiality and anonymity of participant’s data. Participants have been 
promised these values as part of the informed consent process.  
 
What is critical to quality assurance is the role of RECs in monitoring whether 
informed consent is being obtained as reflected in the protocol. It is argued that 
it is one thing to reflect the desired requirements on paper but what happens in 
the field may be totally different. While the REC‘s monitoring of the informed 
consent process ought to be the gold standard, it is highly aspirational. Even in 
the developed world where the IRB’s do not function under the terrible resource 
constraints of RECs of the developing world, monitoring the conduct of research 
is not always the norm. 
  
South Africa, like many developing countries is a hotbed for research activities. 
At the same time there is an exponential growth of independent ethics 
committees. It is important that the functioning of these research ethics 
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committees need to be monitored. At present in South Africa it is informally 
reported that there are about twenty such committees, most are not attached to 
universities or research government entities or institutes (interview: A Dhai) . 
The researchers, quiet a number of whom are medical doctors in private 
practice do research for private companies. Although in general, a current Good 
Clinical Practice certificate is a requirement to conduct research it is not clear 
how many of these researchers adhere to the principle of GCP training. In 
addition, conflicts of interest can be generated by e.g.  large sums of money 
paid to the researcher for every patient in one’s practice enrolled in the study 
could easily compromise ethical principles in the informed consent process. 
There is a paucity of studies on the obtaining of informed consent from one’s 
own patients in the private sector. This raises ethical concern especially in light 
of the fact that the funders are profit making entities. 
 
At a practical level how does one ensure that the process of obtaining informed 
consent is continuous and following the strict criteria laid out in the protocol? 
This is especially critical in the context of a background with proliferation of 
collaborative research between developed and developing countries,   where 
funding agreements are tightly controlled and based on tight schedules within 
limited time. Currently despite a history of research misconduct, researcher 
integrity is relied upon. REC functioning is based on good faith agreements with 
the researchers: The question that begs an answer is “Is this enough? 
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3) Political Interference in Research Activities 
 
Research activities also reflect a political agenda therefore raising ethical 
problems about informed consent processes in developing countries. The 
promise of anticipated health care services to be given to research participants 
can raise poise ethico-political problems through the interference of politicians. 
Politicians may insist on reviewing and approving protocols, despite no training 
in health or ethics, thereby threatening the independence of a research ethics 
committee. A case in point was in Mpumalanga in South Africa where the REC 
rejected a study on scientific and ethical grounds because it was perceived that 
it would harm some of the research participants (van Bogaert 2007) and mostly 
likely the informed consent could have been jeopardised. It transpired later that 
a newly appointed Member of Executive Committee (MEC) for Health approved 
the study without informing the REC.  
 
Heads of ministries could even demand expedited reviews and approval of 
ethically flawed projects. They may even facilitate research where trials have 
not undergone the review process. This has been aptly demonstrated in the 
case of Mathius Rath who conducted clinical trials with his products of vitamins 
which he publicly claimed cured AIDS. DoH did not stop this vagrant act of 
misinformation until the Treatment Action Campaign (TAC) took Dr Rath to 
Court for making false claims. In the case (TAC and SAMA v Matthias Rath , 
2008), Rath was interdicted and the Department of Health was ordered to 
investigate him. He was also told to stop breaching the (Medicines and Related 
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Substance Act, 101 of 1995). The Act among other objectives gives power to 
the Department of Health to control use of unregistered medicines    
 
4) Slowness of Governments to Facilitate the Formation of National Health 
Research Ethics Councils 
 
National Ethics Councils play a pivotal in setting norms and standards for 
conducting research on human participants, auditing processes and outputs of 
research ethics committees. The advisory role to government and Non 
Government Organisations on issues of research ethics including informed 
consent is also important. There is also a need for the public to air grievances 
and seek redress in matters concerning informed consent in research.  However 
with the exception of a few countries, very few functioning councils have been 
established. One of the reasons could be that, where the burden of disease is 
such a high priority and research is urgently needed for solutions by 
governments, research ethics committees are perceived as stumbling blocks to 
initiating research. In South Africa the National Health Research Council 
(NHREC) was established in 2006. The functions of NHREC according to NHA, 
includes among others registering and auditing of research ethics committee 
and also give guidance on how research ethics committees should function. 
Thus far the functioning of the committee has remained an enigma. It was only 
recently that the NHREC registered RECs.  As the Council serves a three year 
term which comes to an end in 2009, it is clear that not much has been 
achieved by the first council. However, of importance the administrative 
structures are in place. 
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5) Open Debate and Civic Engagement  
 
Despite the proliferation of research in developing countries there is hardly any 
public debate concerning on the ethical issue of informed consent in biomedical 
research. Granted, community involvement should take place prior to research 
where informed consent is discussed, but this is usually within the 
circumscribed areas where research is to take place. I argue that there is a 
need to open the debate to a bigger audience. This failure may be explained by 
the fact that firstly biomedical researchers on human participants are 
programmed to announce positive results to the public especially if the research 
results are of high political national interest, the processes leading to the actual 
research results  take low importance. Secondly, as informed consent in 
developing countries is a contentious issue, not many researchers might be 
amenable to public debate when the key challenges and concerns might be that 
of recruiting sufficient participants and sourcing adequate funding. This does not 
in any way infer that there is unethical intent on the researchers’ part, or that 
there are ulterior motives to keep down the debate. Thirdly, as the concept of 
obtaining informed consent for research purposes is so complex and 
contentious, researchers may be wary of discussing such an issue because of 
the media’s tendency to distort facts.  Research agencies have are also to be 
mentioned because when they  put calls in the local media for recruits to 
participate in research issues of informed consent are not clarified up front in 
the criteria for participation. 
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The public in general including health workers are not conversant about ethics 
of research especially on the issues of the ethics of obtaining informed consent. 
This might be explained by the fact that bioethics is still a new field in 
developing countries. This is true also of South Africa. This is borne out by the 
fact that bioethics teaching at university level in South Africa as an example has 
only recently been made compulsory in the curriculum of health science 
students. Increasing awareness and dialogue would ensure that that people 
know that they have the right not to participate in research and, if they do so 
under what the conditions should be to ensure ethical research. There role of 
civic society should not be undermined in the facilitation of this process. Civic 
groups are in touch with communities at grass root levels as they have 
tremendous capacity to network. They also have the ability to galvanise 
community participation, especially the poor, thus acting as a vehicle for them to 
voice their concerns.  
 
Recommendations 
 
In this report I have identified unfinished business areas in the issue of informed 
consent. I have detailed the issue of IC in International and National documents 
and from ethical and legal views; I have shown that such documents do not 
present a deterrent to obtaining informed consent. I have further suggested that 
it is naive on the part of some persons who claim that the guidelines should be 
relaxed because of cultural differences.  This is because they fail to include the 
fact that all cultures change, the more-so with globalization. In the previous 
chapter I have pin-pointed the areas to target. The areas can be summarized as 
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follows; capacity strengthening and training of research ethics committees to 
asses protocols, strict monitoring of research processes in the field, curtailing of 
political interference in research activities to ensure that research ethics 
committees do their work independently and by actively encouraging  of  
vigorous debate on issues of informed consent in research by civil society . 
 
This is not to undermine the complexes of obtaining informed consent .Although 
there was an outcry about the individual autonomy in developing countries, the 
acceptance of the multi step approach in obtaining consent in communitarian 
societies has eased this tension as it has not overridden individual consent 
which is core to ethics. This is great step forward in matters concerning 
informed consent for developing countries. 
 
I have highlighted the importance of informed consent in research and its 
elements have been dissected fully, recommendations about its universalism in 
its application in diverse communities is well explained , but much more work 
needs to be done in the areas I have mentioned.  
 
Is there some unfinished business in informed consent in developing countries? 
Yes there is. 
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